|Bid||3.95 x 800|
|Ask||4.85 x 1300|
|Day's Range||4.1000 - 4.2800|
|52 Week Range||4.0900 - 9.4800|
|Beta (3Y Monthly)||1.80|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 6, 2018 - Mar 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.50|
IRIDEX Corporation (IRIX) today announced Chief Financial Officer Atabak Mokari will leave the Company for a senior finance executive role at another company. Mokari has agreed to assist in the orderly transition of his CFO responsibilities and will leave the Company effective December 18, 2018. IRIDEX plans to search for a replacement.
NEW YORK, Nov. 16, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
If you are currently a shareholder in IRIDEX Corporation (NASDAQ:IRIX), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested. Read More...
Iridex (IRIX) delivered earnings and revenue surprises of 10.34% and 17.40%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Mountain View, California-based company said it had a loss of 26 cents. The medical laser company posted revenue of $11.3 million in the period. Iridex expects full-year revenue ...
MOUNTAIN VIEW, Calif., Nov. 01, 2018 -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 29, 2018..
MOUNTAIN VIEW, Calif., Oct. 25, 2018 -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in upcoming investor conferences. IRIDEX’s.
Glaucoma and Retina Specialists Will Discuss the Benefits of MicroPulse® Technology MOUNTAIN VIEW, Calif., Oct. 23, 2018 -- IRIDEX Corporation (Nasdaq:IRIX), a leading.
MOUNTAIN VIEW, Calif., Oct. 18, 2018 -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter 2018 after the close.
IRIDEX Corporation (IRIX) today announced the appointment of Dr. Robert Grove to the Company’s Board of Directors effective October 15, 2018. Concurrently, Ann Rhoads will step down from the Board of Directors to focus attention on her new responsibility as Chief Financial Officer of Forty Seven Inc. “Bob is a perfect fit for our Board of Directors and will be an excellent addition,” said William M. Moore, Chairman and Chief Executive Officer.
Anyone researching IRIDEX Corporation (NASDAQ:IRIX) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. InvestorsRead More...
The offering is expected to close on September 18, 2018, subject to customary closing conditions. Gross proceeds to the Company from the offering are expected to be approximately $10,000,000 before deducting the underwriting discount and other offering expenses payable by the Company and excluding any exercise of the underwriters' option.
IRIDEX Corporation (IRIX) ("IRIDEX" or the "Company"), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. IRIDEX also expects to grant the underwriters for the offering a 30-day option to purchase an additional 15% of the shares of its common stock offered in the public offering. All of the shares to be sold in the offering are to be sold by IRIDEX. IRIDEX intends to use the net proceeds from the offering for working capital and other general corporate purposes.
The Mountain View, California-based company said it had a loss of 28 cents per share. The medical laser company posted revenue of $10.3 million in the period. Iridex expects full-year revenue in the range ...
IRIDEX Corporation (NASDAQ:IRIX), a medical equipment company based in United States, led the NasdaqGM gainers with a relatively large price hike in the past couple of weeks. As a smallRead More...
On a per-share basis, the Mountain View, California-based company said it had a loss of 31 cents. The medical laser company posted revenue of $9.5 million in the period. Iridex shares have declined 27 ...